Diagnosis and treatment of herpangina: Chinese expert consensus
Tóm tắt
Từ khóa
Tài liệu tham khảo
Chen C. Clinical and epidemiological features of herpangina. Inter J Epidemiol Infect Dis. 2016;43:270–3 (in Chinese).
Jiang DF, Shen KL, Shen Y. Zhu futang practice of pediatrics. 8th ed. Beijing: People’s Medical Publishing House; 2015 (in Chinese).
Li JM, Li L, Gao L, Dong XC, Liu H. Characteristics of herpangina epidemic and related environmental impact factors in Tianjin. J Environ Health. 2018;35:326–9 (in Chinese).
Li W, Gao HH, Zhang Q, Liu YJ, Tao R, Cheng YP, et al. Large outbreak of herpangina in children caused by enterovirus in summer of 2015 in Hangzhou China. Sci Rep. 2016;6:35388.
Peng Q, Xie MY, Zhang YH, Liu Q, Li WR, Li SP, et al. Molecular epidemiology of the enteroviruses associated with hand, foot and mouth disease/herpangina in Dongguan, China, 2015. Arch Virol. 2016;161:3463–71.
Yao X, Bian LL, Lu WW, Li JX, Mao QY, Wang YP, et al. Epidemiological and etiological characteristics of herpangina and hand foot mouth diseases in Jiangsu, China, 2013–2014. Hum Vaccin Immunother. 2017;13:823–30.
Zeng HR, Zheng HY, Liu L, Lu J, Tan XH, Sun LM, et al. Etiological characteristics of herpangina cases in Guangzhou city in Guangdong province, 2015. Chin J Exp Clin Virol. 2017;31:409–13 (in Chinese).
Puenpa J, Mauleekoonphairoj J, Linsuwanon P, et al. Prevalenceand characterization of enterovirus infections among pediatric patients with hand foot mouth disease, herpangina and influenzalike illness in Thailand, 2012. PLoS One. 2014;906:9888.
Li XW, Ni X, Qian SY, Wang Q, Jiang RM, Xu WB, et al. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition). World J Pediatr. 2018;36:257–63.
Wang WP, Sun K, Chang LW. Pediatrics. In: Qu SQ, editor. Acute upper respiratory infection. 9th ed. Beijing: People’s Medical Publishing House; 2018. p. 240–2 (in Chinese).
Takechi M, Fukushima W, Nakano T, Inui1 M, Ohfuji S, Kase T, et al. Nationwide Survey of Pediatric inpatients with hand, foot, and mouth disease, herpangina, and associated complications during an epidemic period in Japan: estimated number of hospitalized patients and factors associated with severe cases. J Epidemiol; 2018.
Deng HL, Jiang RM, Li XW, Qian SY, Wang Q, Chen Q, et al. Differential diagnosis of hand-foot-mouth disease. Chin J Clin. 2018;46:760–3 (in Chinese).
Lin H, Huang L, Zhou J, Lin KC, Wang HJ, Xue X, et al. Efficacy and safety of interferon-α2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial. Arch Virol. 2016;161:1–8.
Yao TX, Liao YN, Gu F, Yu SJ, Yin F. Clinical effect of recombinant human interferon α-2b spray on herpangina in children. Chin Pediatr Integr Tradit West Med. 2017;9:427–9 (in Chinese).